Introduction
Every year 6% of worldwide births, about 7.9 million infants, are born with major birth defects. Of them, almost 3.2 million are disabled for life. In the United States, birth defects are number one cause of mortality in children below 1 year of age and account for nearly 20% of all infant deaths. In about 10% of these malformations an etiologic agent has been identified, whether environmental, biologic or nutritional. While up to 20% of the cases are attributable to chromosomal abnormalities, the remaining 70% has no known cause yet. [1] [2] [3] [4] Congenital diaphragmatic hernia (CDH) is a serious and life threatening anomaly that occurs in 1 out of every 2 to 3 thousands live births. Abnormal retinoic acid pathway has been implicated as a possible cause but its etiology remains unknown. Despite new treatment modalities, including extracorporeal membrane oxygenation, high frequency ventilation and fetal or postnatal surgery, it is still associated with mortality rates as high as 40%. [5] [6] [7] [8] [9] [10] Gastroschisis and omphalocele, collectively abdominal wall defects (AWD), have a prevalence of about 1 in every 2000 births. The prognosis of such anomalies has continued to improve throughout the years and has seen an increase in survival from 60% during the 1960 to almost 90% in recent years. The improvement in survival is largely due to the improvement in surgical techniques and neonatal care. However, the incidence of gastroschisis has increased in recent years especially among newborns delivered to young mothers. Regional variations have been noted in some areas, suggesting other factors than genetics to be involved in its etiology. [11] [12] [13] [14] [15] [16] [17] [18] Unlike congenital anomalies mentioned above, neural tube defects (NTD) are one of those where a nutritional deficiency has been linked to it. Folic acid deficiency during early pregnancy was identified as a 'proven' associated risk factor. In 1998, the US Food and Drug Administration mandated adding folic acid to all cereal grain products. Since then there has been a decrease in the prevalence of spina bifida by 22 .9% compared with [1995] [1996] . NTD has a prevalence rate of about 1 in 4500 birth. [19] [20] [21] Although general prevalence of congenital anomalies among US newborns is well-determined, geographic distribution of most of these anomalies have not been adequately studied. Identifying the regional distribution of a disease has many merits. It allows health care providers to assess regional health care needs and provide proper health care plans. More importantly, defining regions or clusters of birth defects could allow researchers to discover environmental or socio-economic risk factors for such disease. In a study conducted in Malta, an island in the Mediterranean, significant regional difference in the prevalence of congenital heart disease was noted between its South-East compared with its North-West region. Another study conducted in Bohemia, in Eastern Europe, arrived to the same conclusion regarding the impact of environmental factors in the etiology of congenital heart defects. 22, 23 With these findings in mind, we embarked on this journey to examine the regional distribution of CDH, AWD and NTD in the United States. We have chosen these distinct three congenital anomalies because: (a) they affect three different body systems, (b) they take place during different phases of fetal development and (c) each one represents a spectrum of variable presentations in its category that may reflect an accumulative influence of environmental exposure in addition to a genetic predisposition. We aimed to: (1) identify regional variations in the prevalence of these three different congenital anomalies in the United States, (2) examine the interaction of newborn's birth region, sex and race on the prevalence of these diseases and (3) examine these differences in minority groups, such as Asian and Native Americans. Our hypothesis is that there is no difference in the distribution of these congenital anomalies among newborns in different race/ethnic backgrounds or across different regions of the United States.
Methods

Database
We used the de-identified database produced by the Healthcare Cost and Utilization Project (HCUP) from the federal Agency for Healthcare Research and Quality (AHRQ). HCUP data sets are one of the largest health care data sets in the United States. They are reproduced from an all-payer national database collected annually from millions of inpatient hospitalization records and reflect more than 1000 hospitals across the United States. This database represent various care levels (primary-tertiary), types of insurance (public, private) and academic settings (university, general). Data in hospitalization records are coded using the International Classification of Disease 9 (ICD-9) for different clinical variables and Current Procedural Terminology (CPT) for different procedures done for every patient during hospitalization. The database include more than 100 data elements for each patient for every hospital stay, such as: patient's demographics, primary and secondary diagnoses, primary and secondary procedures, source of admission, discharge status and disposition, information on health care providers, expected payment source, and total charges.
HCUP produced the Nationwide Inpatient Sample (NIS) data set and its pediatrics version; Kids' Inpatients Database (KID). NIS data set represents 10% sample of admissions during any given year for patients of all ages from participating hospitals. KID data set has similar data elements but only for pediatric patients and is produced once every 3 years. We used the KID data set from the years 1997, 2000 and 2003, and NIS data set for the years: 1998, 1999, 2001, 2002 and 2004 that were available at the time of running this analysis.
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We extracted the following information for each patient: newborn-related ICD codes, sex, race/ethnicity, hospital state, source of admission (delivery room, emergency room, transfer from another medical facility and so on), neonatal diagnoses, procedures accumulated during the hospitalization, disposition at discharge and whether dead or alive during the hospitalization.
Combined data sets have a total of 44 744 318 hospital admission records for adults and pediatric patients collected between 1997 and 2004. After applying inclusion and exclusion criteria, 4 143 086 hospital admission records for newborns delivered during the studied 8 years in 28 states from the four US regions were used for the analysis.
Patient selection and identification
We included hospital discharge records for infants who have ICD-9 diagnostic codes referring to newborn period. We excluded: (a) newborns with missing codes for sex, race or where race was documented as 'other', (b) newborns with missing codes for location of birth or newborns delivered in Hawaii or Alaska (both states are not included in mainland North American US regions and have different environmental circumstances that may alter the prevalence of certain disease) and (c) newborns transferred out from the hospital of birth (to avoid duplicate inclusion at both birth and receiving hospitals).
We identified newborns with CDH using the ICD-9 diagnostic codes 756.6. Those who had surgery for CDH were identified using CPT codes: 537, 5371 to 2, 5375, 538 and 5380 to 4. We identified gastroschisis and omphalocele infants using the codes 756.79 (used for both diseases during the studied years). Those who had surgery for either condition were identified using CPT codes: 547 and 5471 to 5. NTD infants were identified using the codes: 741, 741.0, 741.00 to 03, 741.1 to 3, 741.9 and 741.90 to 93. Those who had surgery for NTD were identified using CPT codes: 035, 0351 to 2 and 0359. To assure the reliability of included patients, we considered a true diagnosis for any of the three congenital anomalies only if the hospital admission record had an ICD-9 diagnostic code for the disease and had either a CPT code for a surgical procedure related to the disease before disposition or a newborn that expired before discharge. Permission to conduct this study was obtained from the institutional review board at the George Washington University Medical Center.
Data management and analysis
We classified newborns according to their state of birth into four groups: Northeast, South, Midwest and West similar to the classification of US census of bureau. 26 We calculated the prevalence for each disease in the overall sample, then classified by sex, race/ethnicity and region of birth. The prevalence of a disease in the sample was calculated using the formula: ((number of newborns with a CPT code for related surgical procedure for that disease) þ (number of newborns with the diagnostic code for the disease but died before surgery) divided by (total number of newborns included in the sample)).
We used SAS 9.1 (Cary, NC, USA) for the statistical analysis. w 2 and Fisher exact tests were used to calculate odds ratio (OR) and confidence intervals (CI). Prevalence of any of the three diseases in the sample was found to be the least among newborns delivered in the Northeast region. Northeast was selected to be the reference region for comparisons. White race was the most predominant in the sample and was used as the reference for the race/ethnicity comparisons. Male sex was used as the reference for sex comparisons. We calculated OR for newborns to have a disease if they belong to one race versus others and one sex versus the other in the overall population and in each geographic region. We calculated OR for newborns to have a disease if born in any region of the US compared with Northeast for each individual race and each sex. Due to the multiplicity of comparisons conducted in this stratified analysis, we considered P value to be significant only if it is <0.01 to avoid reporting statistically significant but clinically irrelevant results. There were 1291 newborns diagnosed with CDH representing a prevalence of 0.031% (B1:3200). Newborns that had AWD were 2184 representing 0.052% (B1.1900). Newborns who had NTD were 979 representing 0.024% (B1:4200) ( Tables 1-3) .
Results
Male
Distribution of CDH across the US regions
Among newborns with CDH, sex influenced prevalence significantly with females at a 20 increased risk for CDH in the overall population (OR 1.2 (CI: 1.1-1.4, P<0.001)). Race impacted the prevalence of CDH; African Americans have the least risk compared with Caucasians (OR ¼ 0.78 (CI: 0.7-0.9, P ¼ 0.004)) (Supplementary Appendix C).
There was significant interaction between sex, race and birth region in relation to the prevalence of CDH among US newborns. Compared with the Northeast, newborns born in any of the other three US regions had more risk for CDH. The West region was the highest (OR ¼ 1.62 (CI: 1.4-1.9, P<0.001)). African American race had the least prevalence of CDH; however, when stratified by regions, the racial link to lower risk for African Americans was only prevalent in the South region (OR ¼ 0.67 (CI: 0.5-0.8, P ¼ 0.001)). Although the West region had the highest incidence of CDH, the influence of birth region was only noticeable in males (and not in females) both in the African American and the Hispanic populations. Meanwhile, female-to-male risk disparities were most observed among Caucasians only in the South (OR ¼ 1.44 (CI: 1.1-1.8, P ¼ 0.003)). There was no significant difference for Asian or Native Americans compared with Caucasians either overall or when stratified by sex or region of births ( Table 1) . Newborns delivered in any of the US regions had higher prevalence of AWD compared with Northeast, with the Midwest and the South being the highest; (OR ¼ 2.07 (CI: 1.8-2.4, P<0.001)) and (OR ¼ 1.99 (CI: 1.7-2.3, P<0.001)), respectively. The higher prevalence for AWD among Native Americans was most prevalent in the West and Midwest (OR ¼ 5.1 (CI: 2.7-9.6, P<0.001)). On the contrary, the increased AWD in Hispanics were most prominent in the South. The lower prevalence among Asians was seen in the West (OR ¼ 0.46 (CI: 0.3-0.7, P<0.001)), but among African Americans was more evident in the South. When stratified by race and sex, regional differences were observed in both sexes in Caucasians but only in males among Hispanics (Table 2) .
Distribution of AWD across the US regions
NTD across the US regions
Caucasian females in the Northeast had less risk for NTD compared with males. No other apparent significance for sex on the prevalence of NTD among US newborns was detected. Hispanics in the South had more (OR ¼ 1.33 (CI: 1.2-1.5, P<0.001)) but Asians in the West had less NTD (OR ¼ 0.27 (CI: 0.2-0.5, P<0.001)) compared with Caucasians (Supplementary Appendix E).
All regions of the United States had higher prevalence for NTD compared with Northeast especially in the Midwest (OR ¼ 2.14 (CI: 1.7-2.7, P<0.001)). Less Caucasian females had NTD compared with males in the Northeast (OR 0.45 (CI: 0.3-0.7, P<0.001)).
The increased prevalence of NTD among Hispanics newborns was mainly attributed to births that took place in the South (OR ¼ 1.52 (CI: 1.2-1.9, P<0.001)). While the protective effect noticed among Asian was notable only in the West (OR ¼ 0.13 (CI: 0.04-0.4, P<0.001)). The regional difference noted was mainly due to more prevalence among Caucasians males and females delivered in any US region compared with the Northeast (Table 3) .
Discussion
This study showed that there was no significant impact for sex in regards to the prevalence of any of the examined congenital anomalies except among Caucasians. White females had more CDH especially if were born in the South but less NTD when born in the Northeast. Other races had no significant male to female differences across any US regions. African Americans had less chance to have any of the congenital anomalies compared with Caucasians in overall comparisons. Regional stratification showed this difference to be concentrated mainly in the South region. Asians delivered in the West region had less prevalence of AWD and NTD compared with Caucasians. Hispanic newborns did not differ from Caucasians in regards to CDH but had more AWD and NTD mainly in the South. Although, less use of folate supplement among Hispanics was suggested by some authors to explain such increase in the prevalence of NTD, it cannot explain the increase in AWD as well. Native Americans did not have significant differences from Caucasians expect if delivered in the West or Midwest and only for AWD.
Newborns delivered in any of the US regions have higher prevalence for all of the examined congenital anomalies compared with Northeast. Caucasians newborns were found to have less chance for any of the selected diseases when delivered in Northeast compared with any other region in the United States. This fact was true for both sexes. African American females had more AWD in any region compared with Northeast, whereas African American Published data had a discrepancy in regard to sex differences of CDH, with some suggesting higher in males, while others suggested more in females. No difference was seen in previous studies in regards to effect of race/ethnicity or geographic region on CDH. [5] [6] [7] [8] [9] [10] Our data showed higher prevalence for CDH in Caucasians females born in the South region.
There was more AWD among Hispanic and Native American newborns but less in African Americans and Asians compared with Caucasians. These findings are relatively consistent with previously published data in regards to the less prevalence of AWD among African Americans and Asians. However, the high prevalence among Hispanics and Native Americans was not confirmed before. It was shown previously that the largest percentage of gastroschisis takes place in the South, but no regional comparison was done to check for significance. [11] [12] [13] [14] [15] [16] [17] This study shows a range of 1.75-2.07 OR for AWD if newborns were delivered in any region of the country compared with Northeast.
On the contrary, previous studies had shown more prevalence of NTD among Hispanics and less among African Americans and Asians compared with Caucasians especially in the West region. Bold values indicate statistically significant results (Pp0.01). *Odds ratios cannot be calculated.
Our study adds the finding of less NTD among Caucasian females but only in the Northeast not nationwide. 'Asian Americans' is a poorly defined term and practically includes several race/ethnic groups. East, South, Southwest, North and West Asians are from distinct heritage lines. Unfortunately, HCUP data as well as other national data sets collectively refer to all individuals from Asia as 'Asians' regardless of their specific heritage lineage. Future studies on relationship of race with diseases should consider further stratifications to better describe Asian Americans. In this study, Asians had less prevalence of CDH, AWD and NTD when compared with Caucasians, but only in the population residing in the West region and with no significant female to male difference. Native Americans did not differ from Caucasians in regard to CDH or NTD, nor did they have any sex or geographical differences among themselves for the three diseases. However, they had the highest prevalence of AWD among all races. This was very evident among those who resided in the West and Midwest regions. A finding that needs further exploration as Native American tribes resided in different parts of the United States and such a statistical difference may relate to specific tribal heritage.
Findings in this study have relevant public health implications. Obstetricians should be familiar of the difference in the prevalence of the examined diseases in different race groups in different parts of the United States and council pregnant mothers accordingly. Health officials serving minorities like Native Americans shall be aware of the increased risk for AWD among their newborns to run proper diagnostic tests during pregnancy and be ready with proper resources at delivery.
This study had several strength points. First, it is a nationally collected database that included a significantly large sample size (n ¼ 4 143 086). Second, the sample was homogenously distributed across US regions. Third, the study included all live births in participating hospitals with or without the disease. Fourth, it calculated the prevalence of each disease based on actual procedure performed or mortality related to the disease (excluding all 'suspected but not confirmed' cases; mainly those who did not have corrective surgical procedure and were discharged home). Fifth, data included infants from several hunderds of hospitals sampled from 28 states with different types of payment options, care levels and management strategies; such diversity better reflected the entire nation's medical, geographic, ethnic, social and economic conditions. Sixth, the analyses and some of the findings were novel; we are not aware of any previous analysis to target such number of states in all US regions stratified by race and sex.
Using a large national database has its own limitations. Not all needed items of data were always available. In both HCUP data sets (NIS and KID), there were a number of records that did not have ICD code for race, sex or state of birth or the race was recorded as 'other' (all excluded). Another limitation was the inability to include fetal demises, stillbirths or infants who died in delivery rooms with no admission records that might have any of the selected congenital malformations. We also could not include any diagnoses that were obtained via autopsy of non-admitted birth products. Therefore, our results may underestimate the actual prevalence of any of the selected diseases. 'Hidden' mortality in infants with congenital malformation is a common problem in all the epidemiologic studies and its discussion is beyond the scope of this report.
In conclusion, this study demonstrated birth region to be as detrimental as sex and race in affecting the prevalence of CDH, AWD and NTD across US. These findings demonstrate a significant role for environmental factors in the pathogenesis of these diseases. Further studies are needed to examine the role of geographic location on the prevalence of other congenital diseases and to correlate specific environmental variables with the pathogenesis of these diseases.
